Company Filing History:
2 out of 343 
2 out of 3 Years Active: 2010-2012
Title: Anna Maria Naggi: Innovator in Glycosaminoglycan Research
Introduction
Anna Maria Naggi is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of glycosaminoglycan research, particularly in developing derivatives with unique properties. With a total of 4 patents, her work has garnered attention for its potential applications in medical science.
Latest Patents
Naggi's latest patents include innovative compounds that focus on the antiangiogenic activity of partially desulphated glycosaminoglycans. One of her notable patents describes derivatives of heparin that exhibit antiangiogenic activity while being devoid of anticoagulant effects. Another patent highlights the use of these derivatives as heparanase inhibitors, further emphasizing their therapeutic potential.
Career Highlights
Throughout her career, Anna Maria Naggi has worked with esteemed organizations such as Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Sigma-Tau Research Switzerland S.a. Her research has significantly advanced the understanding of glycosaminoglycans and their applications in medicine.
Collaborations
Naggi has collaborated with notable colleagues in her field, including Benito Casu and Giangiacomo Torri. These partnerships have contributed to the success and impact of her research.
Conclusion
Anna Maria Naggi's innovative work in glycosaminoglycan research showcases her dedication to advancing medical science. Her patents reflect her commitment to developing effective therapeutic solutions.